ClearPoint Neuro CLPT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$246K-149% | $506K-44.5% | $912K+4.6% | ||
| $40.61M+9.9% | $36.97M+7.7% | $34.33M+2.2% | $33.59M+4.2% | $32.24M+2.7% | ||
| $15.3M+7.1% | $14.28M+7.5% | $13.28M-0.1% | $13.3M+6.3% | $12.51M+1.9% | ||
| $25.32M+11.6% | $22.69M+7.8% | $21.05M+3.7% | $20.3M+2.9% | $19.73M+3.2% | ||
| 62.3%+1.0pp | 61.4%+0.1pp | 61.3%+0.9pp | 60.4%-0.8pp | 61.2%+0.3pp | ||
| $15.04M+8.2% | $13.9M-0.7% | $13.99M+1.0% | $13.86M+5.4% | $13.15M+6.1% | ||
| $17.41M+5.5% | $16.5M+15.2% | $14.32M+3.2% | $13.87M+4.8% | $13.24M+10.5% | ||
| $19.34M+17.5% | $16.46M+6.2% | $15.5M+1.9% | $15.21M+1.2% | $15.02M+3.8% | ||
| -$26.48M-9.6% | -$24.16M-6.2% | -$22.76M-0.5% | -$22.64M-4.4% | -$21.68M-9.9% | ||
| -65.2%+0.2pp | -65.4%+0.9pp | -66.3%+1.1pp | -67.4%-0.1pp | -67.3%-4.4pp | ||
| —— | —— | —— | —— | $388.5K-25.0% | ||
| —— | —— | —— | —— | $1.19M-14.1% | ||
| -$185K-26.7% | -$146K-21.7% | -$120K-79.1% | -$67K-570% | -$10K+75.0% | ||
| -$29.02M-13.9% | -$25.49M-10.2% | -$23.12M-4.2% | -$22.2M-6.8% | -$20.78M-9.9% | ||
| $45K-18.2% | $55K— | —— | —— | —— | ||
| -$29.07M-13.8% | -$25.54M-10.4% | -$23.14M-4.1% | -$22.22M-6.9% | -$20.79M-9.9% | ||
| -71.6%-2.5pp | -69.1%-1.7pp | -67.4%-1.2pp | -66.2%-1.6pp | -64.5%-4.3pp | ||
| -$1.01-11.0% | -$0.91-8.3% | -$0.84-3.7% | -$0.81-6.6% | -$0.76-8.6% | ||
| -$1.01-11.0% | -$0.91-8.3% | -$0.84-3.7% | -$0.81-6.6% | -$0.76-8.6% | ||
| 114.5M+1.6% | 112.7M+1.2% | 111.4M+0.8% | 110.6M+0.7% | 109.8M+2.1% | ||
| 114.5M+1.6% | 112.7M+1.2% | 111.4M+0.8% | 110.6M+0.7% | 109.8M+2.1% | ||
| -$185K-26.7% | -$146K-21.7% | -$120K-79.1% | -$67K-570% | -$10K+75.0% | ||
| -$26.48M-9.6% | -$24.16M-6.2% | -$22.76M-0.5% | -$22.64M-4.4% | -$21.68M-9.9% | ||
| -$25.68M-10.0% | -$23.35M-6.4% | -$21.95M-1.5% | -$21.63M-3.8% | -$20.84M-11.1% | ||
| -$25.68M-10.0% | -$23.35M-6.4% | -$21.95M-1.5% | -$21.63M-3.8% | -$20.84M-11.1% | ||
| -63.2%-0.1pp | -63.2%+0.8pp | -63.9%+0.5pp | -64.4%+0.3pp | -64.7%-4.9pp | ||
| -$26.48M-9.6% | -$24.16M-6.2% | -$22.76M-0.5% | -$22.64M-4.4% | -$21.68M-9.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ClearPoint Neuro's revenue?
- ClearPoint Neuro (CLPT) generated $40.6M in revenue over the trailing twelve months, up 26.0% year over year.
- Is ClearPoint Neuro profitable?
- ClearPoint Neuro is not currently profitable: it reported a net loss of $29.1M over the trailing twelve months, a -71.6% net margin.
- What are ClearPoint Neuro's profit margins?
- Gross margin is 62.3% and operating margin is -65.2%, with a -71.6% net margin.
- What is ClearPoint Neuro's earnings per share?
- ClearPoint Neuro's diluted EPS over the trailing twelve months is $-1.01.
- Where does ClearPoint Neuro's income statement data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
